First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Mice

This is a "connection" page, showing publications Karl-Erik Andersson has written about Mice.
Connection Strength

1.354
  1. Andersson KE. Oxidative stress and its possible relation to lower urinary tract functional pathology. BJU Int. 2018 04; 121(4):527-533.
    View in: PubMed
    Score: 0.088
  2. Guimarães-Souza NK, Yamaleyeva LM, Lu B, Ramos AC, Bishop CE, Andersson KE. Superoxide overproduction and kidney fibrosis: a new animal model. Einstein (Sao Paulo). 2015 Jan-Mar; 13(1):79-88.
    View in: PubMed
    Score: 0.072
  3. Füllhase C, Campeau L, Sibaev A, Storr M, Hennenberg M, Gratzke C, Stief C, Hedlund P, Andersson KE. Bladder function in a cannabinoid receptor type 1 knockout mouse. BJU Int. 2014 Jan; 113(1):144-51.
    View in: PubMed
    Score: 0.067
  4. Gedda L, Björkelund H, Lebel L, Asplund A, Dubois L, Wester K, Penagos N, Malmqvist M, Andersson K. Evaluation of real-time immunohistochemistry and interaction map as an alternative objective assessment of HER2 expression in human breast cancer tissue. Appl Immunohistochem Mol Morphol. 2013 Dec; 21(6):497-505.
    View in: PubMed
    Score: 0.067
  5. Campeau L, Füllhase C, Sawada N, Gratzke C, Hedlund P, Howlett AC, Andersson KE. Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro. Neurourol Urodyn. 2014 Jun; 33(5):566-70.
    View in: PubMed
    Score: 0.065
  6. Hicks AN, Campeau L, Burmeister D, Bishop CE, Andersson KE. Lack of nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2): consequences for mouse bladder development and function. Neurourol Urodyn. 2013 Nov; 32(8):1130-6.
    View in: PubMed
    Score: 0.063
  7. Ishizuka O, Imamura T, Kurizaki Y, Nishizawa O, Andersson KE. Male lower urinary tract symptoms and a1D-adrenoceptors. Int J Urol. 2013 Jan; 20(1):73-8.
    View in: PubMed
    Score: 0.062
  8. Kanai A, Zabbarova I, Oefelein M, Radziszewski P, Ikeda Y, Andersson KE. Mechanisms of action of botulinum neurotoxins, ß3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol Urodyn. 2012 Mar; 31(3):300-8.
    View in: PubMed
    Score: 0.059
  9. Andersson KE, Soler R, Füllhase C. Rodent models for urodynamic investigation. Neurourol Urodyn. 2011 Jun; 30(5):636-46.
    View in: PubMed
    Score: 0.056
  10. Andersson KE, Gratzke C, Hedlund P. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int. 2010 Oct; 106(8):1114-27.
    View in: PubMed
    Score: 0.053
  11. Gedda L, Björkelund H, Andersson K. Real-time immunohistochemistry analysis of embedded tissue. Appl Radiat Isot. 2010 Dec; 68(12):2372-6.
    View in: PubMed
    Score: 0.052
  12. Soler R, Füllhase C, Lu B, Bishop CE, Andersson KE. Bladder dysfunction in a new mutant mouse model with increased superoxide--lack of nitric oxide? J Urol. 2010 Feb; 183(2):780-5.
    View in: PubMed
    Score: 0.051
  13. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007 Nov; 100(5):987-1006.
    View in: PubMed
    Score: 0.044
  14. Benigni F, Baroni E, Zecevic M, Zvara P, Streng T, Hedlund P, Colli E, D'Ambrosio D, Andersson KE. Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis. BJU Int. 2006 Mar; 97(3):617-24.
    View in: PubMed
    Score: 0.039
  15. Hedlund P, Matsumoto K, Andersson KE. Animal models of erectile dysfunction. Curr Protoc Pharmacol. 2005 Jul; Chapter 5:Unit5.41.
    View in: PubMed
    Score: 0.037
  16. Igawa Y, Zhang X, Nishizawa O, Umeda M, Iwata A, Taketo MM, Manabe T, Matsui M, Andersson KE. Cystometric findings in mice lacking muscarinic M2 or M3 receptors. J Urol. 2004 Dec; 172(6 Pt 1):2460-4.
    View in: PubMed
    Score: 0.036
  17. Schröder A, Newgreen D, Andersson KE. Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J Urol. 2004 Sep; 172(3):1166-70.
    View in: PubMed
    Score: 0.035
  18. Schröder A, Pandita RK, Hedlund P, Warner M, Gustafsson JA, Andersson KE. Estrogen receptor subtypes and afferent signaling in the bladder. J Urol. 2003 Sep; 170(3):1013-6.
    View in: PubMed
    Score: 0.033
  19. Schröder A, Uvelius B, Newgreen D, Andersson KE. Bladder overactivity in mice after 1 week of outlet obstruction. Mainly afferent dysfunction? J Urol. 2003 Sep; 170(3):1017-21.
    View in: PubMed
    Score: 0.033
  20. Butler DSC, Ambite I, Nagy K, Cafaro C, Ahmed A, Nadeem A, Filenko N, Tran TH, Andersson KE, Wullt B, Puthia M, Svanborg C. Neuroepithelial control of mucosal inflammation in acute cystitis. Sci Rep. 2018 07 20; 8(1):11015.
    View in: PubMed
    Score: 0.023
  21. Ihara T, Mitsui T, Nakamura Y, Kira S, Nakagomi H, Sawada N, Hirayama Y, Shibata K, Shigetomi E, Shinozaki Y, Yoshiyama M, Andersson KE, Nakao A, Takeda M, Koizumi S. Clock Genes Regulate the Circadian Expression of Piezo1, TRPV4, Connexin26, and VNUT in an Ex Vivo Mouse Bladder Mucosa. PLoS One. 2017; 12(1):e0168234.
    View in: PubMed
    Score: 0.021
  22. Ihara T, Mitsui T, Nakamura Y, Kira S, Miyamoto T, Nakagomi H, Sawada N, Hirayama Y, Shibata K, Shigetomi E, Shinozaki Y, Yoshiyama M, Andersson KE, Nakao A, Takeda M, Koizumi S. The Clock mutant mouse is a novel experimental model for nocturia and nocturnal polyuria. Neurourol Urodyn. 2017 04; 36(4):1034-1038.
    View in: PubMed
    Score: 0.020
  23. Kim J, Andersson KE, Jackson JD, Lee SJ, Atala A, Yoo JJ. Downregulation of metabolic activity increases cell survival under hypoxic conditions: potential applications for tissue engineering. Tissue Eng Part A. 2014 Aug; 20(15-16):2265-72.
    View in: PubMed
    Score: 0.017
  24. Aro E, Bastman S, Andersson KE, Streng T. Is there a peripheral site of action contributing to the voiding effects of a2-adrenoceptor agonists and antagonists? World J Urol. 2015 Mar; 33(3):433-40.
    View in: PubMed
    Score: 0.017
  25. Dubois L, Andersson K, Asplund A, Björkelund H. Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods. BMC Res Notes. 2013 Dec 18; 6:542.
    View in: PubMed
    Score: 0.017
  26. Altai M, Varasteh Z, Andersson K, Eek A, Boerman O, Orlova A. In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors. Cancer Biother Radiopharm. 2013 Apr; 28(3):187-95.
    View in: PubMed
    Score: 0.016
  27. Ko IK, Lee BK, Lee SJ, Andersson KE, Atala A, Yoo JJ. The effect of in vitro formation of acetylcholine receptor (AChR) clusters in engineered muscle fibers on subsequent innervation of constructs in vivo. Biomaterials. 2013 Apr; 34(13):3246-55.
    View in: PubMed
    Score: 0.016
  28. Orlova A, Hofström C, Strand J, Varasteh Z, Sandstrom M, Andersson K, Tolmachev V, Gräslund T. [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours. Eur J Nucl Med Mol Imaging. 2013 Feb; 40(3):439-49.
    View in: PubMed
    Score: 0.016
  29. Hicks AN, Lorenzetti D, Gilley J, Lu B, Andersson KE, Miligan C, Overbeek PA, Oppenheim R, Bishop CE. Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo. PLoS One. 2012; 7(10):e47869.
    View in: PubMed
    Score: 0.015
  30. Li K, Yao J, Sawada N, Kitamura M, Andersson KE, Takeda M. ß-Catenin signaling contributes to platelet derived growth factor elicited bladder smooth muscle cell contraction through up-regulation of Cx43 expression. J Urol. 2012 Jul; 188(1):307-15.
    View in: PubMed
    Score: 0.015
  31. Huijbers EJ, Femel J, Andersson K, Björkelund H, Hellman L, Olsson AK. The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development. Vaccine. 2012 Jan 05; 30(2):225-30.
    View in: PubMed
    Score: 0.014
  32. Ekman M, Andersson KE, Arner A. Receptor-induced phasic activity of newborn mouse bladders is inhibited by protein kinase C and involves T-type Ca2+ channels. BJU Int. 2009 Sep; 104(5):690-7.
    View in: PubMed
    Score: 0.012
  33. Aboushwareb T, Zhou G, Deng FM, Turner C, Andersson KE, Tar M, Zhao W, Melman A, D'Agostino R, Sun TT, Christ GJ. Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol Urodyn. 2009; 28(8):1028-33.
    View in: PubMed
    Score: 0.012
  34. Ekman M, Andersson KE, Arner A. Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder. BJU Int. 2009 Jan; 103(1):90-7.
    View in: PubMed
    Score: 0.012
  35. Delo DM, Eberli D, Williams JK, Andersson KE, Atala A, Soker S. Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue. BJU Int. 2008 Sep; 102(7):878-84.
    View in: PubMed
    Score: 0.011
  36. Hodges SJ, Zhou G, Deng FM, Aboushwareb T, Turner C, Andersson KE, Santago P, Case D, Sun TT, Christ GJ. Voiding pattern analysis as a surrogate for cystometric evaluation in uroplakin II knockout mice. J Urol. 2008 May; 179(5):2046-51.
    View in: PubMed
    Score: 0.011
  37. Lu B, Poirier C, Gaspar T, Gratzke C, Harrison W, Busija D, Matzuk MM, Andersson KE, Overbeek PA, Bishop CE. A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice. Biol Reprod. 2008 Apr; 78(4):601-10.
    View in: PubMed
    Score: 0.011
  38. Tolmachev V, Orlova A, Pehrson R, Galli J, Baastrup B, Andersson K, Sandström M, Rosik D, Carlsson J, Lundqvist H, Wennborg A, Nilsson FY. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule. Cancer Res. 2007 Mar 15; 67(6):2773-82.
    View in: PubMed
    Score: 0.010
  39. Lagou M, De Vente J, Kirkwood TB, Hedlund P, Andersson KE, Gillespie JI, Drake MJ. Location of interstitial cells and neurotransmitters in the mouse bladder. BJU Int. 2006 Jun; 97(6):1332-7.
    View in: PubMed
    Score: 0.010
  40. Tolmachev V, Nilsson FY, Widström C, Andersson K, Rosik D, Gedda L, Wennborg A, Orlova A. 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. J Nucl Med. 2006 May; 47(5):846-53.
    View in: PubMed
    Score: 0.010
  41. Ekman M, Andersson KE, Arner A. Developmental regulation of nerve and receptor mediated contractions of mammalian urinary bladder smooth muscle. Eur J Pharmacol. 2006 Feb 17; 532(1-2):99-106.
    View in: PubMed
    Score: 0.010
  42. Lagou M, Gillespie JI, Andersson KE, Kirkwood T, Drake MJ. Bladder volume alters cholinergic responses of the isolated whole mouse bladder. J Urol. 2006 Feb; 175(2):771-6.
    View in: PubMed
    Score: 0.010
  43. Streng TK, Talo A, Andersson KE, Santti R. A dose-dependent dual effect of oestrogen on voiding in the male mouse? BJU Int. 2005 Nov; 96(7):1126-30.
    View in: PubMed
    Score: 0.010
  44. Persson M, Tolmachev V, Andersson K, Gedda L, Sandström M, Carlsson J. [(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells. Eur J Nucl Med Mol Imaging. 2005 Dec; 32(12):1457-62.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.